Research Study Summary
Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems in the Treatment of Subjects With Atherosclerotic De Novo or Restenotic Lesions in the Native Superficial Femoral Artery and/or Native Proximal Popliteal Artery.
This study is for patients with moderate to severe blockages in the superficial femoral artery (SFA) and/or proximal popliteal artery (PPA) in the leg. This study is designed to determine the safety and effectiveness of the Absolute Pro Peripheral Self-Expanding Stent System and may reduce critical limb ischemia and major limb amputation. The study involves a 3 year follow-up that includes physical exam, x-ray, ultrasound, and quality of life questionnaires.
To Learn more
Date Last Changed:
July 19, 2013
Clinical Trial Snapshot
- Both Male and Female
- Overall Status
- Facility Type
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.